...Health info at your doorstep

Day: 5 April 2021

Covid-19: France Enters Third National Lockdown Amid ICU Surge

Covid-19: France Enters Third National Lockdown Amid ICU Surge

NEWS
  France has entered its third national lockdown as it battles a surge in cases of Covid-19 that threatens to overwhelm the country's hospitals. All schools and non-essential shops will shut for four weeks, and a curfew will be in place from 19:00 to 06:00. On Friday, the number of seriously ill Covid patients in intensive care units (ICU) increased by 145 - the biggest jump in five months. President Emmanuel Macron has promised more hospital beds for Covid patients. France is currently battling a peak of about 5,000 Covid patients in ICUs. On Friday, the country recorded 46,677 new cases and 304 deaths. As well as the restrictions that came into force on Saturday, from Tuesday people will also need a valid re...
Lingering Questions About AstraZeneca Vaccine

Lingering Questions About AstraZeneca Vaccine

Coronavirus, NEWS
  Persistent questions on whether rare but serious blood clots among those getting the AstraZeneca vaccine against COVID-19 are more frequent than in the general population, and what causes them if they are, have continued to undermine confidence in the beleaguered vaccine. The European Medicines Agency — which has said that benefits outweigh risks such that the vaccine should remain in use — will provide an updated assessment next week. What has been observed? The blood clots seen in a handful of people vaccinated with AstraZeneca are described by the French Medicines Agency (ANSM) as “highly untypical”. “This thrombosis of large veins is unusually located in the brain, and even more rarely in the digestive tract,” the agency commented. It is also associated with
FG Directs States to Halt COVID-19 Vaccination Halfway

FG Directs States to Halt COVID-19 Vaccination Halfway

Coronavirus
  The Federal Government has asked all the states administering the COVID-19 vaccine to stop the exercise the moment they use half of the doses allocated to them. Sunday PUNCH, through its investigations, found that the Executive Director of the National Primary Health Care Development Agency, Dr. Faisal Shuaibu, had asked all the states to suspend vaccination when they reach half of the doses delivered to them. This implies that a state that was given 100,000 doses would have to halt the vaccine rollout once the doses hit 50,000 in order for those who have received their first jab to be able to complete their vaccination. The move, it was learnt, had become necessary due to a possible delay in the supply of the next batch of the AstraZeneca vaccines, which could affec
Troubling “Eek” Variant Found in Most Tokyo Hospital COVID Cases – NHK

Troubling “Eek” Variant Found in Most Tokyo Hospital COVID Cases – NHK

Coronavirus, NEWS
Around 70% of coronavirus patients tested at a Tokyo hospital last month carried a mutation known for reducing vaccine protection, Japanese public broadcaster NHK said on Sunday. The E484K mutation, nicknamed "Eek" by some scientists, was found in 10 of 14 people who tested positive for the virus at Tokyo Medical and Dental University Medical Hospital in March, the report said. For the two months through March, 12 of 36 COVID patients carried the mutation, with none of them having recently travelled abroad or reporting contact with people who had, it said. Hospital officials were not immediately available for comment. Ahead of the summer Olympics scheduled to begin in July, Japan is grappling with a new wave of infections. Health experts are particularly concerned about...
And now a ‘Quicker, Kinder’ Breast Cancer Treatment

And now a ‘Quicker, Kinder’ Breast Cancer Treatment

Women's health
A new five-minute breast cancer treatment is being rolled out in England in a bid to dramatically reduce the amount of time patients spend in hospital, The Telegraph reports. More than 3,600 women a year are expected to benefit from the injection, which combines two drugs currently administered as separate intravenous infusions, says Yahoo News, quoting the medium. Treatment with the prescription medicine, Phesgo, will be offered to breast cancer patients undergoing chemotherapy who have the HER2-positive form of the disease, about 15 percent of all breast cancer sufferers, it says. Currently they are forced to spend roughly two-and-a-half hours in hospital to receive the treatment. Although the NHS plans to roll out the jab in hospitals, its quick and portable format raise